Vaxart's market cap is currently ―. The company's EPS TTM is $-0.575; its P/E ratio is -2.24; Vaxart is scheduled to report earnings on May 8, 2024, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 2.10M	$ 1.33M	$ 397.00K	-	$ 0.00
Gross Profit	$ 2.10M	$ 1.36M	-	-	-
EBIT	$ -17.36M	$ -22.53M	$ -25.75M	$ -24.50M	$ -28.97M
EBITDA	-	$ -20.36M	$ -23.69M	$ -22.61M	$ -27.41M
Net Income Common Stockholders	$ -17.19M	$ -22.55M	$ 27.41M	$ -23.92M	$ -29.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 19.80M	$ 67.91M	$ 71.81M	$ 95.72M	$ 114.77M
Total Assets	$ 105.64M	$ 122.65M	$ 129.85M	$ 153.85M	$ 175.31M
Total Debt	$ 20.46M	$ 21.00M	$ 21.52M	$ 21.70M	$ 22.17M
Net Debt	$ 660.00K	$ -46.91M	$ -50.30M	$ -74.01M	$ -92.60M
Total Liabilities	$ 34.12M	$ 37.58M	$ 40.10M	$ 153.85M	$ 53.00M
Stockholders Equity	$ 71.52M	$ 85.07M	$ 89.75M	$ 110.60M	$ 122.31M
Cash Flow	-
Free Cash Flow	-	$ -17.93M	$ -25.70M	$ -33.05M	$ -16.64M
Operating Cash Flow	$ -15.00M	$ -17.47M	$ -24.46M	$ -29.15M	$ -14.62M
Investing Cash Flow	$ 4.97M	$ -1.58M	$ 25.46M	$ 15.80M	$ -31.07M
Financing Cash Flow	$ -8.00K	$ 13.90M	$ 1.42M	$ 8.60M	$ 4.99M

Currency in USD

Vaxart Earnings and Revenue History

Income Statement >

Vaxart Debt to Assets

Balance Sheet >

Vaxart Cash Flow

Cash Flow >

Vaxart Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing